2012年863计划生物医药技术领域项目公示

2012-02-17 MedSci MedSci原创

为深入落实国家“十二五”科技规划确定的战略任务,科技部2011年4月启动了2012年度国家科技计划的申报立项工作,在各有关单位组织推荐的基础上,按照《国家高技术研究发展计划(863计划)管理办法》(国科发计[2011]363 号),经视频答辩、专家咨询、方案论证、项目查重等程序,凝练形成了2012年度国家863计划备选项目。这批备选项目将根据国家科技计划预算落实情况安排立项。   按

为深入落实国家“十二五”科技规划确定的战略任务,科技部2011年4月启动了2012年度国家科技计划的申报立项工作,在各有关单位组织推荐的基础上,按照《国家高技术研究发展计划(863计划)管理办法》(国科发计[2011]363 号),经视频答辩、专家咨询、方案论证、项目查重等程序,凝练形成了2012年度国家863计划备选项目。这批备选项目将根据国家科技计划预算落实情况安排立项。
 
按照“竞争、公开、择优、问责”的计划组织实施原则,为进一步增加国家科技计划管理的透明度,现就2012年度国家863计划生物和医药技术领域备选项目进行公示。公示时间为2012年2月9日—2012年2月17日。
 
联系人:孙燕荣(58881438)
 
 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=4133, encodeId=cff1413333, content=感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=woodslee429, createdTime=Sat Mar 24 18:13:00 CST 2012, time=2012-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4093, encodeId=a9164093f3, content=要是在细化点就更好了,呵呵, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4ae57359, createdName=anruihenry, createdTime=Tue Mar 06 09:51:00 CST 2012, time=2012-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4046, encodeId=6777404690, content=非常有用!, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5c954718, createdName=haier521, createdTime=Wed Feb 22 09:04:00 CST 2012, time=2012-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4047, encodeId=d2ad404e13, content=非常有用!, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5c954718, createdName=haier521, createdTime=Wed Feb 22 09:04:00 CST 2012, time=2012-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4048, encodeId=a4644048b3, content=非常有用!, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5c954718, createdName=haier521, createdTime=Wed Feb 22 09:04:00 CST 2012, time=2012-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408587, encodeId=e8b5140858e3a, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Feb 19 05:01:00 CST 2012, time=2012-02-19, status=1, ipAttribution=)]
    2012-03-24 woodslee429

    感谢

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=4133, encodeId=cff1413333, content=感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=woodslee429, createdTime=Sat Mar 24 18:13:00 CST 2012, time=2012-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4093, encodeId=a9164093f3, content=要是在细化点就更好了,呵呵, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4ae57359, createdName=anruihenry, createdTime=Tue Mar 06 09:51:00 CST 2012, time=2012-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4046, encodeId=6777404690, content=非常有用!, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5c954718, createdName=haier521, createdTime=Wed Feb 22 09:04:00 CST 2012, time=2012-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4047, encodeId=d2ad404e13, content=非常有用!, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5c954718, createdName=haier521, createdTime=Wed Feb 22 09:04:00 CST 2012, time=2012-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4048, encodeId=a4644048b3, content=非常有用!, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5c954718, createdName=haier521, createdTime=Wed Feb 22 09:04:00 CST 2012, time=2012-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408587, encodeId=e8b5140858e3a, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Feb 19 05:01:00 CST 2012, time=2012-02-19, status=1, ipAttribution=)]
    2012-03-06 anruihenry

    要是在细化点就更好了,呵呵

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=4133, encodeId=cff1413333, content=感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=woodslee429, createdTime=Sat Mar 24 18:13:00 CST 2012, time=2012-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4093, encodeId=a9164093f3, content=要是在细化点就更好了,呵呵, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4ae57359, createdName=anruihenry, createdTime=Tue Mar 06 09:51:00 CST 2012, time=2012-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4046, encodeId=6777404690, content=非常有用!, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5c954718, createdName=haier521, createdTime=Wed Feb 22 09:04:00 CST 2012, time=2012-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4047, encodeId=d2ad404e13, content=非常有用!, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5c954718, createdName=haier521, createdTime=Wed Feb 22 09:04:00 CST 2012, time=2012-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4048, encodeId=a4644048b3, content=非常有用!, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5c954718, createdName=haier521, createdTime=Wed Feb 22 09:04:00 CST 2012, time=2012-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408587, encodeId=e8b5140858e3a, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Feb 19 05:01:00 CST 2012, time=2012-02-19, status=1, ipAttribution=)]
    2012-02-22 haier521

    非常有用!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=4133, encodeId=cff1413333, content=感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=woodslee429, createdTime=Sat Mar 24 18:13:00 CST 2012, time=2012-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4093, encodeId=a9164093f3, content=要是在细化点就更好了,呵呵, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4ae57359, createdName=anruihenry, createdTime=Tue Mar 06 09:51:00 CST 2012, time=2012-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4046, encodeId=6777404690, content=非常有用!, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5c954718, createdName=haier521, createdTime=Wed Feb 22 09:04:00 CST 2012, time=2012-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4047, encodeId=d2ad404e13, content=非常有用!, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5c954718, createdName=haier521, createdTime=Wed Feb 22 09:04:00 CST 2012, time=2012-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4048, encodeId=a4644048b3, content=非常有用!, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5c954718, createdName=haier521, createdTime=Wed Feb 22 09:04:00 CST 2012, time=2012-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408587, encodeId=e8b5140858e3a, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Feb 19 05:01:00 CST 2012, time=2012-02-19, status=1, ipAttribution=)]
    2012-02-22 haier521

    非常有用!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=4133, encodeId=cff1413333, content=感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=woodslee429, createdTime=Sat Mar 24 18:13:00 CST 2012, time=2012-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4093, encodeId=a9164093f3, content=要是在细化点就更好了,呵呵, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4ae57359, createdName=anruihenry, createdTime=Tue Mar 06 09:51:00 CST 2012, time=2012-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4046, encodeId=6777404690, content=非常有用!, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5c954718, createdName=haier521, createdTime=Wed Feb 22 09:04:00 CST 2012, time=2012-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4047, encodeId=d2ad404e13, content=非常有用!, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5c954718, createdName=haier521, createdTime=Wed Feb 22 09:04:00 CST 2012, time=2012-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4048, encodeId=a4644048b3, content=非常有用!, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5c954718, createdName=haier521, createdTime=Wed Feb 22 09:04:00 CST 2012, time=2012-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408587, encodeId=e8b5140858e3a, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Feb 19 05:01:00 CST 2012, time=2012-02-19, status=1, ipAttribution=)]
    2012-02-22 haier521

    非常有用!

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=4133, encodeId=cff1413333, content=感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=woodslee429, createdTime=Sat Mar 24 18:13:00 CST 2012, time=2012-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4093, encodeId=a9164093f3, content=要是在细化点就更好了,呵呵, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4ae57359, createdName=anruihenry, createdTime=Tue Mar 06 09:51:00 CST 2012, time=2012-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4046, encodeId=6777404690, content=非常有用!, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5c954718, createdName=haier521, createdTime=Wed Feb 22 09:04:00 CST 2012, time=2012-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4047, encodeId=d2ad404e13, content=非常有用!, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5c954718, createdName=haier521, createdTime=Wed Feb 22 09:04:00 CST 2012, time=2012-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4048, encodeId=a4644048b3, content=非常有用!, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5c954718, createdName=haier521, createdTime=Wed Feb 22 09:04:00 CST 2012, time=2012-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408587, encodeId=e8b5140858e3a, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Feb 19 05:01:00 CST 2012, time=2012-02-19, status=1, ipAttribution=)]
    2012-02-19 cathymary